NY Hospital

Robert McInnis, MD, is an Assistant Professor of Clinical Neurology at Weill Cornell Medical College. He received his M.D. from Boston University School of Medicine where he was inducted into Alpha Omega Alpha Honor Society, and was the recipient of the Scholars Award from the Massachusetts Medical Society. Dr. McInnis completed his internship in Internal Medicine at the Massachusetts’s General Hospital, and Neurology Residency jointly at the Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA. He subsequently completed a two-year Epilepsy Fellowship at the University of California, San Francisco, in San Francisco, CA.Dr. McInnis is interested in teaching medical students and neurology trainees, and has research interests in artificially intelligent EEG analysis, and in improving delivery of epilepsy and neurology care.

Frank A. Petito, MD, received his medical degree M.D. from Columbia-Presbyterian Medical College. He completed his internship and residency training in neurology at The New York Hospital. He is certified by The American Board of Psychiatry and Neurology and was recently named as one of the top doctors in his field by New York Magazine. Dr. Petito is an expert in the diagnosis and treatment of all aspects of neurologic disorders. His particular interest lies in the areas of headache and Multiple Sclerosis. For Consultation/Referral/ Appointment please call: (212) 746-2309.

Dr. Justin Kaner graduated with a B.S. in Biology from Syracuse University in 2009 where his initial interest in hematologic malignancies developed. He received his M.D. from New York Medical College in 2013 before completing his Internal Medicine Residency at Albert Einstein College of Medicine/Montefiore Medical Center. During residency Dr. Kaner pursued his interest in hematologic malignancies by undertaking several research projects mainly focused on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) which led to several publications in peer reviewed journals, including Leukemia and Lymphoma and Oncotarget, as well as numerous abstracts presented at the American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) Annual Meetings. Additionally, Dr. Kaner served as Chief Resident after his residency at Montefiore Medical Center.Throughout his Hematology/Oncology fellowship at Weill Cornell Medicine and NewYork-Presbyterian Hospital, Dr. Kaner worked in the laboratory of Dr. Monica Guzman and with clinical mentorship from Dr. Ellen Ritchie and Dr. Gail Roboz of the Weill Cornell Leukemia Program. During this time, he studied the activity of a novel therapeutic, PU-H71, in PTPN11 mutated AML as well as the prognostic impact of PTPN11 mutations in AML. During his fellowship training Dr. Kaner also developed a particular interest in early phase clinical trials and novel therapeutics for the treatment of Relapsed/Refractory AML. Dr. Kaner accepted an opportunity to remain at Weill Cornell, joining the Leukemia Program to focus on caring for hospitalized patients with various acute and chronic leukemias, MDS and myeloproliferative neoplasms (MPNs).